Skip to main content
SpringerLink
Log in

Einleitung

  • Chapter
Physiologische Anleitung zu einer zweckmäßigen Ernährung

  • 12 Accesses

Zusammenfassung

Auf der Schule haben wir den Satz gelernt: „Wir essen, um zu leben: wir leben nicht, um zu essen“.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Eichelbaum M (1975). Ein neuentdeckter Defet im Arzneimittelstoffwechsel des Menschen: Die fehlende N-Oxidation des Spartein. Habilitationsschrift, Medizinische Fakultät Rheinischen Friedrich-Wilhelms-Universität, Bonn.

    Google Scholar 

  2. Eichelbaum M, Spannbrucker N, Steincke B and Dengler HJ (1979). Defective N-oxidation of sparteine in man: A new pharmacogenetic defect. Eur J Clin Pharmacol. 16, 183–187.

    CAS  PubMed  Google Scholar 

  3. Maghoub A, Idle JR, Dring LG, Lancester R and Smith RL (1977). Polymorphic hydroxylation of debrisoquine in man. Lancet II, 584–586.

    Google Scholar 

  4. Eichelbaum M, Baur MP, Osikowska-Evers, BO, Tieves G, Zekorn C and Rittner C (1987). Chromosomal assignement of human cytochrome P450 (debrisoquine/sparteine type) to chromosome 22. Br J Clin Pharmac 23, 455–458

    CAS  Google Scholar 

  5. Skoda RC, Gonzalez FJ, Demierre A and Meyer UA (1988). Two mutant alleles of the human cytochrome P 450 dbl-gene (P450 C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc Natl Acad Sci. USA 85, 5240–5243

    CAS  PubMed  Google Scholar 

  6. Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Handwick JP and Meyer UA (1988a). Characterization of the common genetic defect in humans deficient in debrisoquin metabolism. Nature 331, 442–446.

    CAS  PubMed  Google Scholar 

  7. Kagimoto M, Heim M, Kagimoto K, Zeugin T and Meyer UA (1990). Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. J Biol Chem 265, 17209–17214.

    CAS  PubMed  Google Scholar 

  8. Heim M and Meyer UA (1990). Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet 336, 529–532.

    CAS  PubMed  Google Scholar 

  9. Gaedigk A, Blum M, Gaedigk R, Eichelbaum M, and Meyer UA (1991). Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am J Human Genet. 48, 943–950.

    CAS  Google Scholar 

  10. Evans, WE and Relling MV (1990). Xbal 16-plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study. Mol. Pharmac 37, 639–642.

    CAS  Google Scholar 

  11. Gonzalez FJ, VILbois F, Hardwick JP, McBride OW, Gelboin HV and Meyer UA (1988b). Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignement of the CYP2D locus to chromosome 22. Genomics 2, 174–179.

    CAS  PubMed  Google Scholar 

  12. Zanger UM, Vilbois F, Hardwick JP and Meyer UA (1988). Absence of hepatic cytochrome P450-bufl causes genetically deficient debrisoquine hydroxylation in man. Biochemistry 27, 5447–5454.

    CAS  PubMed  Google Scholar 

  13. Eichelbaum M and Gross AS (1990). The genetic polymorphism of debrisoquine/sparteine metabolism clinical aspects. Pharmac Ther 46, 377–394.

    CAS  Google Scholar 

  14. Brosen K and Gram LF (1989). Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur. J. Clin. Pharmacol. 36, 537–547.

    CAS  PubMed  Google Scholar 

  15. Hollmann, M., O’Shea-Greenfield, A., Rogers, S.W., and Heinemann, S., Nature 342:643–648 (1989).

    CAS  PubMed  Google Scholar 

  16. Boulter, J., Hollmann, M., O’Shea-Greenfield, A., Hartley, M., Deneris, E., Maron, C., and Heinemann, S., Science 249:1033–1037 (1990).

    CAS  PubMed  Google Scholar 

  17. Bettler, B., Boulter, J., Hermans-Borgmeyer, I., O’Shea-Greenfield, A., Deneris, E., Moll, C, Borgmeyer, U., Hollmann, M., and Heinemann, S., Neuron 5:583–595 (1990).

    CAS  PubMed  Google Scholar 

  18. Edgebjerg, J., Bettler, B., Hermans-Borgmeyer, I., and Heinemann, S., Nature in press (1991).

    Google Scholar 

  19. Braun et al. 1989 EMBO J. 8, 3617–3625

    CAS  PubMed  Google Scholar 

  20. Braun et al. 1989 EMBO J. 8, 701–831

    CAS  PubMed  Google Scholar 

  21. Braun et al. 1990 EMBO J. 9, 821–831

    Google Scholar 

  22. Sassoon et al. 1989 Nature 341, 303–307

    CAS  PubMed  Google Scholar 

  23. Ott et al. 1991 Development 111

    Google Scholar 

  24. Bober et al. 1991 J. Cell. Biol. 112

    Google Scholar 

  25. Braun et al. 1990 Nature 346, 663–665

    CAS  PubMed  Google Scholar 

  26. Murre et al. 1989 Cell 56, 777–783

    CAS  PubMed  Google Scholar 

  27. Braun and Arnold 1991 J.Biol.Chem.(in press)

    Google Scholar 

  28. Salminen et al. 1991 J. Cell. Biol.(in press)

    Google Scholar 

  29. Gerherz et al. 1989 Br. J. Cancer 59, 61–67

    Google Scholar 

  30. Braun et al. 1991 Cell (in press)

    Google Scholar 

  31. Balmain, A and Brown, K. Adv Cancer Res. 51, 147–182 (1988).

    CAS  PubMed  Google Scholar 

  32. Bremner, R and Baimain, A. Cell 61 407–417 (1990).

    CAS  PubMed  Google Scholar 

  33. Bailleul, B, Surani, M A, White, S, Barton, S C, Brown, K, Blessing, M, forcano, J and Balmain, A. Cell 62, 697–708 (1990).

    CAS  PubMed  Google Scholar 

  34. Strathmann, M., T. M. Wilkie and M. I. Simon. Diversity of the G-protein family: Sequences from five additional a subunits in the mouse. Proc. Natl. Acad. Sci. USA 86, 7407–7409, 1989.

    CAS  PubMed  Google Scholar 

  35. Strathmann, M., T. M. Wilkie and M. I. Simon. Alternative splicing produces transcripts encoding two forms of the a subunit of GTP-binding protein GO. Proc. Natl. Acad. Sci. USA 87, 6477–6481, 1990.

    CAS  PubMed  Google Scholar 

  36. Strathmann, M. and M. I. Simon. G protein diversity: A distinct class of a subunits is present in vertebrates and invertebrates. Proc. Natl. Acad. Sci. USA 87, 9113–9117, 1990.

    CAS  PubMed  Google Scholar 

  37. Strathmann, M., B. A. Hamilton, C. A. Mayeda, M. I. Simon, E. M. Meyerowitz and M. J. Palazzolo. Transposon-facilitated DNA sequencing. Proc. Natl. Acad. Sci. USA, 88, 1247–1250 (1991).

    CAS  PubMed  Google Scholar 

  38. Simon, M. I., M. P. Strathmann and N. Gautam. Diversity of G proteins in signal transduction. Science 252, 802–808 (1991).

    CAS  PubMed  Google Scholar 

  39. Amatruda, T. T., m, D. A. Steele, V. Z. Slepak and M. I. Simon. Gα16, a novel G-protein alpha subunit specifically expressed in hematopoietic cells. Proc. Natl. Acad. Sci. USA, in press.

    Google Scholar 

  40. Strathmann, M. P. and M. I. Simon. Gα12 and Gα13 define a fourth class of G protein alpha subunits. Proc. Natl. Acad. Sci. USA, in press.

    Google Scholar 

  41. Bourne, H.R., Sanders, D.A. and McCormick, F. (1990) Nature 348, 125–132.

    CAS  PubMed  Google Scholar 

  42. Bourne, H.R., Sanders, D.A. and McCormick, F. (1991) Nature 349, 117–127.

    CAS  PubMed  Google Scholar 

  43. Hall, A. (1990) Science 249, 635–640.

    CAS  PubMed  Google Scholar 

  44. Walworth, N.C., Goud, B., Kabcenell, A.K. and Novick, P.J. (1989) EMBO J. 8, 1685–1693.

    CAS  PubMed  Google Scholar 

  45. Becker, J., Tan, T.J., Trepte, H.-H. and Gallwitz, D. (1991) EMBO J. 10, 785–792.

    CAS  PubMed  Google Scholar 

  46. Chavrier, P., Parton, R.G., Hauri, H.P., Simons, K. and Zerial, M. (1990) Cell 62, 317–329.

    CAS  PubMed  Google Scholar 

  47. Schatzmann, HJ. The calcium pump of erythrocytes and other animal cells. Membrane Transport of Calcium. (Ed. E. Carafoli), Acad. Press, London, p. 41–108, 1982.

    Google Scholar 

  48. Carafoli, E. Calcium Pump of the Plasma Membrane, Physiol. Rev., 71, p.129–153, 1991.

    CAS  PubMed  Google Scholar 

  49. Niggli, v., Penniston, J.T. and Carafoli, E. Purification of the (Ca2+ + Mg2+)-ATPase from human erythrocyte membranes using a calmodulin affinity column. J. Biol. Chem. 254, p. 9955–9958, 1979.

    CAS  PubMed  Google Scholar 

  50. Verma, A.K., A.G. Filoteo, D.R. Stanford, E.D. Wieben, J.T. Penniston, E.E. Strehler, R. Fischer, R. Heim, G. Vogel, S. Mathews, M.A. Strehler-Page, P. James, T. Vorherr, J. Krebs and E. Carafoli. Complete primary structure of a human plasma membrane Ca2+ pump. J. Biol. Chem. 263: p. 14152–14149, 1988.

    CAS  PubMed  Google Scholar 

  51. Shull, G.E. and J. Greeb. Molecular cloning of two isoforms of the plasma membrane Ca2+ transporting ATPase from rat brain. Structural and functional domains exhibit similarity to Na+, K+- and other cation transport ATPases. J. Biol. Chem. 263: p. 8646–8657, 1988.

    CAS  PubMed  Google Scholar 

  52. Olson, S., M.G. Wang, E. Carafon, E.E. Strehler and O.W. McBride. Localization of two genes encoding plasma membrane Ca2+-transporting ATPases to human chromosomes 1q25–32 and 12q21–23. Genomics 9: 629–641, 1991.

    CAS  PubMed  Google Scholar 

  53. Niggli, V., E.S. Adunyah, J.T. Penniston and E. Carafoli. Purified Ca2+ + Mg2+) ATPase of the erythrocyte membrane: reconstitution and effect of calmodulin and phospholipids. J. Biol. Chem. 256: p. 395–401, 1981.

    CAS  PubMed  Google Scholar 

  54. Campbell KP, Leung AT, Sharp AH (1988) Trends Neurosci. 11:425–430

    CAS  PubMed  Google Scholar 

  55. Catterall WA (1991) Cell 64:871–874

    CAS  PubMed  Google Scholar 

  56. Hofmann F, Nastainczyk W, Röhrkasten A, Schneider T, Sieber M (1987) Trends Pharmacol. Sci. 8:393–398

    CAS  Google Scholar 

  57. Glossmann H, Striessnig J (1990) Rev. Physiol. Biochem. Pharmacol. 114:1–105

    CAS  PubMed  Google Scholar 

  58. Brown AM, Bimbaumer L (1990) Annu. Rev. Physiol. 52:197–213

    CAS  PubMed  Google Scholar 

  59. Callewaert G, Hanbauer I, Morad M (1989) Science 243:663–666

    CAS  PubMed  Google Scholar 

  60. Knaus HG, Scheffauer F, Romanin C, Schindler HG, Glossmann H (1990) J. Biol. Chem. 265:11156–11166

    CAS  PubMed  Google Scholar 

  61. Mintz IM, Venema VJ, Adams ME, Bean BP (1990) Neurosci. Abstr. 16:956

    Google Scholar 

  62. Nunoki K, Florio V, Catterall WA (1989) Proc. Naü. Acad. Sci. (USA) 86:6816–6820

    CAS  Google Scholar 

  63. De Jongh KS, Merrick DK, Catterall WA (1989) Proc. Naü. Acad. Sci. (USA) 86: 8585–8589

    Google Scholar 

  64. Lai Y, Seagar MJ, Takahashi M, Catterall WA (1990) J. Biol. Chem. 265:20839–20848

    CAS  PubMed  Google Scholar 

  65. Röhrkasten A, Meyer HE, Nastainczyk W, Sieber M, Hofmann F (1988) J. Biol. Chem. 263:15325–15329

    PubMed  Google Scholar 

  66. Staudinger R, Knaus HG, Glossmann H (1991) J. Biol. Chem.: in press

    Google Scholar 

  67. Striessnig J, Glossmann H, Catterall WA (1990) Proc. Natl. Acad. Sci. (USA) 87: 9108–9112

    CAS  PubMed  Google Scholar 

  68. Guy HR, Conti F (1990) Trends Neurosci. 13:201–206

    CAS  PubMed  Google Scholar 

  69. Miller C (1991) Science 252:1092–1096

    CAS  PubMed  Google Scholar 

  70. Beavo, J. A. and D. H. Reifsnyder. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 11(4): 150–5.

    CAS  PubMed  Google Scholar 

  71. Le Trong, H, Beier, N, Sonnenburg, W.K., Stroop, S.D., Walsh, K.A., Beavo, J.A. and Charbonneau, H. (1990) Amino acid sequence of the cyclic GMP simulated cyclic nucleotide phosphodiesterase from bovine heart. Biochemistry 29:10280–10288.

    CAS  PubMed  Google Scholar 

  72. Stroop, S.D., Charbonneau, H., and Beavo, J.A. (1989) Direct photolabeling of allosteric and catalytic domains of the cGMP-stimulated cyclic nucleotide phosphodiesterase. J. Biol. Chem. 264:13718–13725.

    CAS  PubMed  Google Scholar 

  73. MacFariand, R.T., Zelus, B., and Beavo, J.A. (1991) High concentrations of a cyclic GMP-stimulated PDE mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J. Biol. Chem. 266:136–142.

    Google Scholar 

  74. Murashima, S., Tanaka, T., Hockman, S., and Manganiello, V. C. (1990). Characterization of a particulate cyclic nucleotide phosphodiesterase from bovine brain: purification of a distinct cGMP-stimulated isoenzyme. Biochemistry 29:5285–5292.

    CAS  PubMed  Google Scholar 

  75. Sonnenburg, W.K., Mullaney, P.J., and Beavo, J.A. (1991) Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA: identification and distribution of isozyme variants. J. Biol. Chem. 266: Sept/Oct (in press).

    Google Scholar 

  76. Moncada S., Palmer R.M.J. and Higgs E.A. (1989). Biochem. Pharmacol., 38: 1709–1715.

    CAS  PubMed  Google Scholar 

  77. Palmer R.M.J., Ferrige A.G. and Moncada S. (1987). Nature, 327: 524–526.

    CAS  PubMed  Google Scholar 

  78. Palmer R.M.J., Ashton D.S. and Moncada S. (1988). Nature, 333: 664–666.

    CAS  PubMed  Google Scholar 

  79. Palmer R.M.J. and Moncada S. (1989). Biochem. Biophys. Res. Commun. 158: 348–352.

    CAS  PubMed  Google Scholar 

  80. Busse R. and Mulsch A. (1990). FEBS Lett., 265: 133–136.

    CAS  PubMed  Google Scholar 

  81. Furchgott R.F. and Zawadzki J.V. (1980). Nature, 288: 373–376.

    CAS  PubMed  Google Scholar 

  82. Schultz K.D., Schultz K. and Schultz G. (1977). Nature, 265: 750–751.

    CAS  PubMed  Google Scholar 

  83. Feelisch M. and Noack E.A. (1987). Eur. J. Pharmacol., 139: 19–30.

    CAS  PubMed  Google Scholar 

  84. Inoue T., Tomoike H., Hisano K. and Nakamura M. (1988). J. Am. Coll. Cardiol., 11: 187–191.

    CAS  PubMed  Google Scholar 

  85. Palmer R.M.J., Rees D.D., Ashton D.S. and Moncada S. (1988). Biochem. Biophys. Res. Commun. 153: 1251–1256.

    CAS  PubMed  Google Scholar 

  86. Rees D.D., Palmer R.M.J., Hodson H.F. and Moncada S. (1989). Br. J. Pharmacol., 96: 418–424.

    CAS  PubMed  Google Scholar 

  87. Rees D.D., Palmer R.M.J. and Moncada S. (1989). Proc. Natl. Acad. Sci. USA. 86: 3375–3378.

    CAS  PubMed  Google Scholar 

  88. Moncada S., Rees D.D., Schulz R. and Palmer R.M.J. (1991). Proc. Natl. Acad. Sci. USA. 88: 2166–2170.

    CAS  PubMed  Google Scholar 

  89. Rees D.D., Cellek S., Palmer R.M.J. and Moncada S. (1990). Biochem. Biophys. Res. Commun. 173: 541–547.

    CAS  PubMed  Google Scholar 

  90. Radomski M.W., Palmer R.M.J. and Moncada S (1990). Proc. Natl. Acad. Sci. USA., 87: 10043–10047.

    CAS  PubMed  Google Scholar 

  91. Busse R. and Mulsch A. (1990). FEBS Lett., 275: 87–90.

    CAS  PubMed  Google Scholar 

  92. Knowles R.G., Salter M., Brooks S.L. and Moncada S. (1990). Biochem. Biophys. Res. Commun., 172: 1042–1048.

    CAS  PubMed  Google Scholar 

  93. Hibbs J.B. Jr., Taintor R.R., Vavrin Z., Granger D.L., Drapier J-C., Amber I.J. and Lancaster J.R. Jr. (1990). In: Nitric oxide from L-arginine. A bioregulatory system, ed. Moncada S. and Higgs E.A. 189–223. Elsevier.

    Google Scholar 

  94. Vallance P. and Moncada S (1991). Lancet, 337: 776–778.

    CAS  PubMed  Google Scholar 

  95. Di Rosa M., Radomski M.W., Carnuccio R. and Moncada S. (1990). Biochem. Biophys. Res. Commun., 172: 1246–1252.

    CAS  PubMed  Google Scholar 

  96. Radomski M.W., Palmer R.M.J. and Moncada S. (1987). Br. J. Pharmacol., 92: 181–187.

    CAS  PubMed  Google Scholar 

  97. Radomski M.W., Palmer R.M.J. and Moncada S. (1987). Biochem. Biophys. Res. Commun., 148: 1482–1489.

    CAS  PubMed  Google Scholar 

  98. Radomski M.W., Palmer R.M.J. and Moncada S. (1990). Proc. Natl. Acad. Sci. USA., 87: 5193–5197.

    CAS  PubMed  Google Scholar 

  99. Moncada S., Palmer R.M.J. and Higgs E.A. (1991). Pharm. Res., 43: 109–142.

    CAS  Google Scholar 

  100. Waldmann SA, Murad F (1987) Cyclic GMP synthesis and function. Pharmacol Rev 39: 163–196

    Google Scholar 

  101. Tremblay J, Gerzer R, Harnet P (1988) Cyclic GMP in cell function. Adv Second Messenger Phosphoprotein Res 22: 319–383

    CAS  PubMed  Google Scholar 

  102. Lincoln TM (1989) Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 41: 479–502

    CAS  PubMed  Google Scholar 

  103. Walter U (1989) Physiological role of cGMP and cGMP-de-pendent protein kinase in the cardiovascular system. Rev Physiol Biochem Pharmacol 113: 41–88

    CAS  PubMed  Google Scholar 

  104. Kaupp UB (1991) The cyclic nucleotide-gated channels of vertebrate photpreceptors and olfactory epithelium. Trends in Neuroscience 14: 150–157

    CAS  Google Scholar 

  105. DiFrancesco D, Tortora P (1991) Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 351: 145–147

    CAS  PubMed  Google Scholar 

  106. Meinecke M, Büchler W, Fischer L, Lohmann SM, Walter U (1990) cAMP-dependent protein kinase: subunit diversity and functional role in gene expression. In: Cellular and molecular biology of myelination (eds. Jeserich G, Althaus HH, Waehneldt TV), NATO ASI Series H, Vol.43, Springer Verlag, Heidelberg, pp 201–215

    Google Scholar 

  107. Taylor SS, Buechler JA, Yonemoto W (1990) cAMP-dependent protein kinase: framework for a diverse family of regulator enzymes. Annu Rev Biochem 59: 971–1005.

    Google Scholar 

  108. Beavo JA (1988) Multiple isoenzymes of cyclic nucleotide phosphodiesterase. Adv Second Messenger and Phosphoprotein Res 22: 1–38

    CAS  Google Scholar 

  109. Beavo JA, Reifsnyder DH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11: 150–155

    CAS  PubMed  Google Scholar 

  110. Mery P-F, Lohmann SM, Walter U, Fischmeister R (1991) Ca++-current is regulated by cGMP-dependent protein kinase in cardiac myocytes. Proc Natl Acad Sci USA 88: 1197–1201

    CAS  PubMed  Google Scholar 

  111. Felbel J, Trockur B, Ecker T, Landgraf W, Hofmann F (1988) Regulation of cytosolic calcium by cAMP and cGMP in freshly isolated smooth muscle cells from bovine trachea. J Biol Chem 263: 16764–16771

    CAS  PubMed  Google Scholar 

  112. Cornwell TL, Lincoln TM (1989) Regulation of intracellular Ca++ levels in cultured vascular smooth muscle cells: reduction of Ca++ by atriopeptin and 8-Br-cGMP is mediated by cGMP-dependent protein kinase. J Biol Chem 264: 1146–1155

    CAS  PubMed  Google Scholar 

  113. Walter U, Nolte C, Geiger J, Schanzenbächer P, Kochsiek K (1991) Inhibition of platelet function by cyclic nucleotides and cyclic nucleotide-dependent protein kinases. In “Antithrombotics: Pathophysiological rationale for pharmacological interventions” (Herman AG, Moncada S, eds.), Kluwer Academic Publishers, In Press

    Google Scholar 

  114. Haibrügge M, Walter U (1989) Purification of a vasodilator-regulated phosphoprotein from human platelets. Eur J Biochem 185: 41–50

    Google Scholar 

  115. Haibrügge M, Friedrich C, Eigenthaler M, Schanzenbächer P, Walter U (1990) Stoichiometric and reversible phosphorylation of a 46 kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. J Biol Chem 265: 3088–3093

    Google Scholar 

  116. Nolte C, Eigenthaler M, Schanzenbächer P, Walter U (1991) Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors. J Biol Chem 266: In press

    Google Scholar 

  117. Wagner D, Metzger R, Paul M, Ludwig G, Suzuki F, Takahashi S, Murakami K, Ganten D. Androgen dependence and tissue specificity of renin messenger RNA expression in mice. J Hypertens 1990;8:45–52

    CAS  PubMed  Google Scholar 

  118. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990;344:541–544

    CAS  PubMed  Google Scholar 

  119. Undpaintner K, Takahashi S, Ganten D. Structural alterations of the renin gene in stroke-prone spontaneously hypertensive rats: examination of genotype-phenotype correlations. J Hypertens 1990;8:763–773

    Google Scholar 

  120. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991;9:3–15

    CAS  PubMed  Google Scholar 

  121. Undpaintner K, Jin M, Niedermeier N, Wilhelm MJ, Ganten D. Cardiac angio-tensinogen and its local activation in the isolated perfused beating heart. Circ Res 1990;67/3:564–573

    Google Scholar 

  122. Colucci WS, et al. N Engl J Med 1986;314:290

    CAS  PubMed  Google Scholar 

  123. Cohn JN. N Engl J Med 1989;320:729

    CAS  PubMed  Google Scholar 

  124. Dies F, et al. Circulation 1986; 74, II:39

    Google Scholar 

  125. Waagstein F, et al. Br Heart J 1975;137:1022

    Google Scholar 

  126. Hasenfuss G, et al. Basic Res Cardiol 1989;84,I:191

    PubMed  Google Scholar 

  127. The Captopril-Digoxin Multicenter Research Group. JAMA 1988;259:539

    Google Scholar 

  128. DiBianco R, et al. N Engl J Med 1989;320:677

    CAS  PubMed  Google Scholar 

  129. Hasenfuss G, et al. Klin Wochenschr 1991;69,XXIII:120

    Google Scholar 

  130. CAST investigators. Prelimnary report: effect of encalnide and flecalnide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med. 1989. 321; 406–412

    Google Scholar 

  131. Ruskln JN. The Cardiac Arrhythmia Suppression Trial (CAST) (editorial). N. Engl. J. Med. 1989. 321; 386–388

    Google Scholar 

  132. The CAPS Investigators. The Cardiac Arrhythmia Pilot Study. Am. J. Cardiol. 1986. 57; 91–95

    Google Scholar 

  133. Evans WE, Relling, MV. Clinical pharmacokinetics-pharmacodynamics of anticancer drugs. Clinical Pharmacokinetics 16: 327–336, 1989.

    CAS  PubMed  Google Scholar 

  134. Evans WE, Crom WR, Stewart CF, et al. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia, New England Journal of Medicine 314:471–477, 1986.

    CAS  PubMed  Google Scholar 

  135. Egorin MJ, Van Echo DA, Olman EA, et al. Prospective validation of a pharmacologically based dosing scheme for carboplatin. Cancer Research 45:5432–5438, 1985.

    Google Scholar 

  136. Rodman JH, Abromowitch M, Sinkule JA, Rivera GK, Evans WE. Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a Phase I trial. Journal of Clinical Oncology 5: 1007–1014, 1987.

    CAS  PubMed  Google Scholar 

  137. Stoller RG, Hande KR, et al. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. New England Journal of Medicine 297: 630–634, 1977.

    CAS  PubMed  Google Scholar 

  138. Milano G, Namer M, Boublil JL, et al. Relationship between systemic 5-FU passage and response in colorectal cancer patients treated with intrahepatic chemotherapy. Cancer Chemotherapy and Pharmacology 20: 71–74, 1987.

    CAS  PubMed  Google Scholar 

  139. Lennard L, Lilleyman JS. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. Journal of Clinical Oncology 7:1816–1823, 1989.

    CAS  PubMed  Google Scholar 

  140. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 336:225–29,1990.

    CAS  PubMed  Google Scholar 

  141. M. Szamel, B. Rehermann, B. Krebs, R. Kurrle, and K. Resch Activation signals in human lymphocytes. Incorporation of polyunsaturated fatty acids into plasma membrane phospholipids regulates interleukin-2 synthesis via sustained activation of protein kinase C. J, Immunol. 143, 2806–2813 (1989)

    CAS  Google Scholar 

  142. M. Szamel, M. Kracht, B. Krebs, U. Hübner, and K. Resch Interleukin 2 synthesis and expression of high affinity interleukin 2 receptors require different signalling for the activation of protein kinase C. Cellular Immunol. 126, 117–128 (1990)

    CAS  Google Scholar 

  143. M. Szamel, B. Rehermann, U. Hübner, and K. Resch Inhibition of T-cell activation by cyclosporin A: inhibition of IL-2 Synthesis via prevention of sustained activation of protein kinase C by interference with the plasma membrane phospholipid metabolism. J. Immunol., submitted

    Google Scholar 

  144. Kahan, B.D. (1989) New England J. Medic. 321, 1725–1738.

    CAS  Google Scholar 

  145. Macleod, A.M. and Thomson, A.W. (1991) Lancet 337, 25–27.

    CAS  PubMed  Google Scholar 

  146. Tocci, M.J., Matkovich, D.A., Collier, K.A., Kwok, P., Dumont, F., Iin, S., Degudicibus, S., Siekierka, J.J., Chin, J. and Hutchinson, N.I. (1989), J. Immunol. 143, 718–726.

    CAS  PubMed  Google Scholar 

  147. Serfling, E., Barthelmäs, R., Pfeuffer, I., Schenk, B., Zarius, S., Mercurio, F. and Karin, M. (1989) EMBO J. 8, 465–473.

    CAS  PubMed  Google Scholar 

  148. Randak, C., Brabletz, T., Hergenröther, M., Sobotta, I. and Serfling, E. (1990) EMBO J. 9, 2529–2536.

    CAS  PubMed  Google Scholar 

  149. Brabletz, T., Pietrowski, I. and Serfling, E. (1991) Nucl. Acids Res. 19,61–67.

    CAS  PubMed  Google Scholar 

  150. Emmel, E.A., Verweij, C.L., Durand, D.B., Higgins, K.M., Lacy, E. and Crabtree, G.R. (1989) Science 226, 1439–1441.

    Google Scholar 

  151. Siekierka, J.J., Hung, S.H.Y., Poe, M., Lin, C.S. and Sigal, N.H. (1989) Nature 341, 755–757.

    CAS  PubMed  Google Scholar 

  152. Tropschug, M., Wachter, E., Mayer, S., Schonbrunner, E.R. and Schmid, F.X. (1990) Nature 346, 674–677.

    CAS  PubMed  Google Scholar 

  153. Goebl, M.G. (1991) Cell 64, 1051–52.

    CAS  PubMed  Google Scholar 

  154. Tanaka, M. and Herr, W. (1990) Cell 60, 375–386.

    CAS  PubMed  Google Scholar 

  155. Greenlee, W.F., R. Osborne, K.M. Dold, L.G. Hudson, M.J. Young, and W.A. Toscano, Jr. (1987). Rev. Biochem. Toxicol. 8: 1.

    CAS  Google Scholar 

  156. Poland, A. and J.C. Knutson (1982). Annu. Rev. Pharmacol. Toxicol. 22:517.

    CAS  PubMed  Google Scholar 

  157. Poland, A. and J.C. Knutson (1982). Annu. Rev. Pharmacol. Toxicol. 22:517.

    CAS  PubMed  Google Scholar 

  158. Sutter, T.R., M.W. Andersen, J.C. Corton, K. Gaido, K. Guzman, and W.F. Greenlee (1991a). Banbury Report 35 (in press).

    Google Scholar 

  159. Sutter, T.R., K. Guzman, K.M. Dold, and W.F. Greenlee (1991b). Toxicologist 11: 988.

    Google Scholar 

  160. Vecchi, A., A. Mantovani, M. Sironi, W. Cairo, and S. Garattini (1980). Chem. Biol. Interact. 30: 337.

    CAS  PubMed  Google Scholar 

  161. Vos, J.G. (1977). CRC Crit. Rev. Toxicol. 5: 67.

    CAS  PubMed  Google Scholar 

  162. Wierda, D. and W.F. Greenlee (1991). In Principles and Practice of Immunotoxicoloav. Blackwell Scientific Pub., London (in press).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituts der Universität Göttingen, Göttingen, Germany

    Dr. Paul Jensen (o. ö. Professor der Physiologie und Direktor des physiologischen)

Authors
  1. Dr. Paul Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Besonderer Hinweis

Dieses Kapitel ist Teil des Digitalisierungsprojekts Springer Book Archives mit Publikationen, die seit den Anfängen des Verlags von 1842 erschienen sind. Der Verlag stellt mit diesem Archiv Quellen für die historische wie auch die disziplingeschichtliche Forschung zur Verfügung, die jeweils im historischen Kontext betrachtet werden müssen. Dieses Kapitel ist aus einem Buch, das in der Zeit vor 1945 erschienen ist und wird daher in seiner zeittypischen politisch-ideologischen Ausrichtung vom Verlag nicht beworben.

Rights and permissions

Reprints and permissions

Copyright information

© 1918 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jensen, P. (1918). Einleitung. In: Physiologische Anleitung zu einer zweckmäßigen Ernährung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-42376-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-42376-9_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-42109-3

  • Online ISBN: 978-3-662-42376-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation